Fibromuscular dysplasia natural history, complications and prognosis: Difference between revisions
Line 12: | Line 12: | ||
**[[Renal]] or cervival artery [[dissection]] | **[[Renal]] or cervival artery [[dissection]] | ||
**[[Intracranial]] [[aneurysms]] [[rupture]] and [[SAH]] | **[[Intracranial]] [[aneurysms]] [[rupture]] and [[SAH]] | ||
**[[Carotid- cavernous fistula]] | **[[Carotid-cavernous]] [[fistula]] | ||
**[[Vertebral arteriovenous fistula]] | **[[Vertebral]] [[arteriovenous]] [[fistula]] | ||
===Prognosis=== | ===Prognosis=== |
Revision as of 02:59, 14 June 2018
Fibromuscular dysplasia Microchapters |
Diagnosis |
---|
Treatment |
ASA/ACCF/AHA Guideline Recommendations |
Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries |
Case Studies |
Fibromuscular dysplasia natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Fibromuscular dysplasia natural history, complications and prognosis |
FDA on Fibromuscular dysplasia natural history, complications and prognosis |
CDC on Fibromuscular dysplasia natural history, complications and prognosis |
Fibromuscular dysplasia natural history, complications and prognosis in the news |
Blogs on Fibromuscular dysplasia natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Natural History, Complications, and Prognosis
Natural History
Complications
- Common complications of FMD include:
- Renal or cervival artery dissection
- Intracranial aneurysms rupture and SAH
- Carotid-cavernous fistula
- Vertebral arteriovenous fistula
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
- Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.